TrialClinical genitourinary cancer2019

Randomized Phase II Trial of Abiraterone Alone or With Dasatinib in Men With Metastatic Castration-resistant Prostate Cancer (mCRPC).

Tanya B Dorff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.